Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

MMWR Morbidity and Mortality Weekly Report

Topics

Medicine

Immunology

Internal Medicine

Pediatrics

Infectious Diseases

Show all topics

DOI

10.15585/mmwr.mm7038e1

Other Formats

PDF